An MRI-guided HIFU-triggered wax-coated capsule for supertargeted drug release: a proof-of-concept study.
Simon MatooriMaurizio RoveriPeter TiefenboeckAnnatina RomagnaOlha WuerthingerOrpheus KolokythasJohannes M FroehlichPublished in: European radiology experimental (2019)
We provide the proof-of-concept of applying a non-invasive MRI-guided HIFU pulse to actively induce the disintegration of the wax-coated capsule, and a method to monitor the release of the cargo via T1-weighted MRI based on the hydration of an encapsulated lyophilised GBCA. The wax-coated capsule platform enables temporally and spatially supertargeted drug release via the oral route and promises to address a currently unmet clinical need for personalised local therapy in gastrointestinal diseases such as inflammatory bowel diseases and cancer.